Coloplast A/S (CLPBY)
12.41
+0.36
(+2.99%)
USD |
OTCM |
May 03, 16:00
Coloplast Max Drawdown (5Y): 47.10% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 47.10% |
| March 31, 2024 | 47.10% |
| February 29, 2024 | 47.10% |
| January 31, 2024 | 47.10% |
| December 31, 2023 | 47.10% |
| November 30, 2023 | 47.10% |
| October 31, 2023 | 47.10% |
| September 30, 2023 | 47.10% |
| August 31, 2023 | 47.10% |
| July 31, 2023 | 47.10% |
| June 30, 2023 | 47.10% |
| May 31, 2023 | 47.10% |
| April 30, 2023 | 47.10% |
| March 31, 2023 | 47.10% |
| February 28, 2023 | 47.10% |
| January 31, 2023 | 47.10% |
| December 31, 2022 | 47.10% |
| November 30, 2022 | 47.10% |
| October 31, 2022 | 47.10% |
| September 30, 2022 | 46.99% |
| August 31, 2022 | 43.63% |
| July 31, 2022 | 43.63% |
| June 30, 2022 | 43.63% |
| May 31, 2022 | 38.17% |
| April 30, 2022 | 28.90% |
| Date | Value |
|---|---|
| March 31, 2022 | 28.90% |
| February 28, 2022 | 25.57% |
| January 31, 2022 | 24.71% |
| December 31, 2021 | 20.64% |
| November 30, 2021 | 20.64% |
| October 31, 2021 | 23.19% |
| September 30, 2021 | 29.59% |
| August 31, 2021 | 31.22% |
| July 31, 2021 | 31.22% |
| June 30, 2021 | 31.22% |
| May 31, 2021 | 31.22% |
| April 30, 2021 | 31.22% |
| March 31, 2021 | 31.22% |
| February 28, 2021 | 31.22% |
| January 31, 2021 | 31.22% |
| December 31, 2020 | 31.22% |
| November 30, 2020 | 31.22% |
| October 31, 2020 | 31.22% |
| September 30, 2020 | 31.22% |
| August 31, 2020 | 31.22% |
| July 31, 2020 | 31.22% |
| June 30, 2020 | 31.22% |
| May 31, 2020 | 31.22% |
| April 30, 2020 | 31.22% |
| March 31, 2020 | 31.22% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
20.64%
Minimum
Nov 2021
47.10%
Maximum
Oct 2022
36.45%
Average
31.22%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| Genmab A/S | 45.75% |
| Ascendis Pharma A/S | 61.72% |
| Galecto Inc | -- |
| Evaxion Biotech AS | -- |
| IO Biotech Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -4.968 |
| Beta (5Y) | 0.6909 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 27.38% |
| Historical Sharpe Ratio (5Y) | 0.0997 |
| Historical Sortino (5Y) | 0.1603 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 12.23% |